We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

159 hedge funds and large institutions have $1.47B invested in Aerie Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 69 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 14

91% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $8.73M

15% more capital invested

Capital invested by funds: $1.28B → $1.47B (+$190M)

5% more funds holding

Funds holding: 151 → 159 (+8)

45% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 69

50% less funds holding in top 10

Funds holding in top 10: 6 → 3 (-3)

Holders
159
Holders Change
+8
Holders Change %
+5.3%
% of All Funds
3.96%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
31
Increased
38
Reduced
69
Closed
14
Calls
$16.7M
Puts
$8.73M
Net Calls
+$7.98M
Net Calls Change
+$4.8M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$116M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.4M
3
SIG
Senator Investment Group
New York
+$17.8M
4
Two Sigma Investments
Two Sigma Investments
New York
+$11.3M
5
Invesco
Invesco
Georgia
+$11M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$46.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$30.7M
3
Jennison Associates
Jennison Associates
New York
-$13.1M
4
PI
Putnam Investments
Massachusetts
-$9.38M
5
ACA
Avoro Capital Advisors
New York
-$8.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
NIP
51
Nicholas Investment Partners
California
$3.73M +$3.67M +82,359 New
CWG
52
C WorldWide Group
Denmark
$3.45M +$179K +4,008 +6%
BI
53
Boulegeris Investments
Georgia
$3.43M -$237K -5,310 -7%
Handelsbanken Fonder
54
Handelsbanken Fonder
Sweden
$3.31M +$3.26M +73,000 New
PPA
55
Parametric Portfolio Associates
Washington
$3.1M +$167K +3,739 +6%
WMSA
56
Weiss Multi-Strategy Advisers
New York
$2.99M – – –
Prudential Financial
57
Prudential Financial
New Jersey
$2.88M +$2.83M +63,530 New
Bank of Nova Scotia
58
Bank of Nova Scotia
Ontario, Canada
$2.79M +$2.74M +61,400 New
Bank of America
59
Bank of America
North Carolina
$2.68M -$461K -10,327 -15%
CM
60
Castleark Management
Illinois
$2.63M +$2.58M +57,890 New
HCM
61
Harvey Capital Management
Florida
$2.59M -$554K -12,425 -18%
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$2.58M -$116K -2,600 -4%
NFA
63
Nationwide Fund Advisors
Ohio
$2.36M -$157K -3,530 -6%
B
64
Bailard
California
$2.29M -$1.45M -32,500 -39%
PA
65
Perceptive Advisors
New York
$2.27M – – –
TA
66
Teachers Advisors
New York
$2.25M +$107K +2,402 +5%
BCA
67
Benchmark Capital Advisors
New York
$2.24M -$526K -11,800 -19%
ACM
68
Asymmetry Capital Management
California
$2.21M -$682K -15,295 -24%
American Century Companies
69
American Century Companies
Missouri
$2.14M -$8.7K -195 -0.4%
Swiss National Bank
70
Swiss National Bank
Switzerland
$2.12M +$161K +3,600 +8%
DCM
71
DAFNA Capital Management
California
$2.12M -$2.3M -51,600 -52%
Barclays
72
Barclays
United Kingdom
$2.12M +$728K +16,315 +54%
HCMT
73
Highland Capital Management (Texas)
Texas
$2.09M +$2.05M +46,000 New
PIM
74
Platinum Investment Management
Australia
$1.93M -$901K -20,200 -32%
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
$1.88M +$349K +7,826 +23%
1 2
3
4 5

AERI Hedge Fund Activity: Q1 2017 in Review

159 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q1 2017, worth a combined $1.47B — up 15% from $1.28B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new AERI positions and 14 closed out — a net gain of 17 holders — while 38 added to existing stakes and 69 trimmed.

The largest buyer was BlackRock, adding an estimated $116M. The largest seller was Deerfield Management, cutting an estimated $46.5M.

  • 159 institutional investors held Aerie Pharmaceuticals (AERI) as of Q1 2017, up from 151 in Q4 2016.
  • Funds reported $1.47B of Aerie Pharmaceuticals stock for Q1 2017, up 15% quarter-over-quarter.
  • 31 funds opened new Aerie Pharmaceuticals positions in Q1 2017 and 14 closed out, a net change of +17 holders.
  • The largest Aerie Pharmaceuticals buyer in Q1 2017 was BlackRock, an estimated $116M added.
  • The largest Aerie Pharmaceuticals seller in Q1 2017 was Deerfield Management, an estimated $46.5M sold.

Based on aggregated 13F filings for Q1 2017.